Options cannabis - Quebec.

02/21/2026

Tellement de bu****it des professionnels bu****iters sur le cannabis….. l’industrie des pharma et alcohol, des experts pour corrompe plusieurs folles en toges….. les cerveau abrutit par un uniforme et un badge…..

Massive 44-year study reveals that long-term cannabis use does not accelerate cognitive decline.

It debunks long-held myths about the drug’s impact on brain aging.

For decades, concerns over the long-term cognitive effects of cannabis have fueled public health warnings, yet a comprehensive 44-year study from Denmark is now challenging those assumptions. Researchers tracked more than 5,000 men from early adulthood into their mid-sixties, comparing intelligence scores recorded at age 20 to follow-up assessments at age 64. The results, published in the journal Brain and Behavior, found no evidence that cannabis use accelerates cognitive decline. In a surprising twist, those with a history of use actually showed a marginally smaller decrease in IQ points—approximately 1.3 points less—than their non-using counterparts, effectively questioning the notion that the drug inevitably impairs long-term mental acuity.

While the findings are striking, experts note that lifestyle factors and 'cognitive reserve' may play a significant role in these outcomes. The study revealed that cannabis users in this cohort often possessed higher baseline IQs and education levels, which are known to influence cognitive resilience. Crucially, the researchers discovered that neither the frequency of use nor the age at which an individual started using the substance significantly impacted their intelligence later in life. Although the study was limited to men and relied on self-reported data, it provides some of the most robust longitudinal evidence to date that past cannabis use does not inherently doom the aging brain to a faster decline.

source: Christensen, T. W., Mortensen, E. L., & Osler, M.. Cannabis use and change in intelligence from age 20 to 64: A 44-year follow-up of 5,162 Danish men. Brain and Behavior.

02/20/2026

The body's endocannabinoid system may be the key.
Cannabinoids mimic molecules the body produces naturally and can bind to receptors on cancer cells. In laboratory settings, this interaction blocked cell growth, starved tumors of blood supply, and commanded programmed cell death. In a glioblastoma trial, patients treated with cannabis-based medicine alongside chemotherapy saw 83% survival at one year versus 44% with placebo.
Street cannabis is not a substitute for clinical-grade treatments. But the findings mark a critical step forward.
Source: Cancer Research UK

02/19/2026

Ma*****na has been studied for its potential effects on the brain, including its interaction with the endocannabinoid system, which plays a role in mood, memory, and neural development. Some animal studies suggest that cannabinoids may influence neurogenesis (the growth of new brain cells), particularly in the hippocampus, a region tied to learning and emotional regulation.

However, scientists emphasize that results are complex: while certain compounds in cannabis may show neurogenic effects in controlled laboratory settings, heavy or long-term use—especially during adolescence—has also been linked to cognitive and mental health risks. The topic remains an active area of research, with ongoing debate about when cannabis may be beneficial versus harmful.



Sources:
Kempermann, G., & colleagues. (2015). Effects of cannabinoids on hippocampal neurogenesis. Brain Structure and Function.

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of ma*****na use. New England Journal of Medicine.

02/19/2026

Bon bon 🤙🏼

02/16/2026

Tout se confirme quand la lumière allume…..

Researchers from University of California, Irvine and University of California, Davis have found that very small doses of psilocybin improved metabolic health in obese mice. The findings were published in the journal Nature Medicine. Scientists observed reduced body weight gain, lower fat accumulation in the liver, and better blood sugar control without triggering strong psychedelic effects.

The study suggests psilocybin may influence serotonin receptors linked to appetite, inflammation, and insulin sensitivity. Researchers believe this could open new pathways for treating obesity, fatty liver disease, and type 2 diabetes. However, experts stress that human trials are still needed to confirm safety and effectiveness before any medical recommendations can be made.

02/15/2026

02/15/2026

Une nouvelle étude suggère qu'une approche combinée pourrait offrir les avantages du traitement au THC dans la maladie d'Alzheimer avec moins d'effets

02/13/2026

Intéressant l’histoire des prohibitions et obligation…….